-
DE
D56.4 is the ICD-10 code for Hereditary Persistence of Fetal Hemoglobin (HPFH), a genetic blood disorder in which fetal hemoglobin remains elevated into adulthood.
Regular tips about health Regular tips about health Add as Preferred SourceD56.4 is the ICD-10 code for Hereditary Persistence of Fetal Hemoglobin (HPFH), a genetic blood disorder in which fetal hemoglobin remains elevated into adulthood.
The ICD-10 code D56.4 refers to Hereditary Persistence of Fetal Hemoglobin (HPFH), a genetically inherited blood disorder belonging to the group of hemoglobinopathies – conditions in which the structure or function of hemoglobin, the red blood cell protein that carries oxygen, is altered.
Under normal circumstances, fetal hemoglobin (HbF), which predominates in the womb, is gradually replaced by adult hemoglobin (HbA) shortly after birth. In HPFH, this switch is incomplete, and HbF remains elevated throughout a person's life.
HPFH is caused by mutations or deletions in the beta-globin gene cluster on chromosome 11. These genetic changes prevent the normal developmental switch from fetal to adult hemoglobin production.
HPFH is inherited in an autosomal pattern, meaning it affects males and females equally. Individuals may be heterozygous (one affected gene copy) or homozygous (both copies affected).
In most cases, isolated HPFH is a benign condition with no clinical symptoms. Elevated HbF levels are often detected incidentally during routine blood tests. Because HbF has a higher oxygen affinity than HbA, it does not typically cause anemia or related symptoms.
HPFH becomes clinically relevant when it co-occurs with other hemoglobinopathies, such as:
The diagnosis of D56.4 is established through several laboratory tests:
Since isolated HPFH generally causes no symptoms, no specific treatment is required. Management is directed at any co-existing hemoglobinopathies.
HPFH is of great scientific interest as a therapeutic model: the artificial reactivation of fetal hemoglobin is a promising strategy for treating sickle cell disease and beta-thalassemia. Medications such as hydroxyurea, as well as emerging gene therapy approaches, aim to increase HbF production by mimicking the mechanism seen in HPFH.
The code D56.4 falls under the group D56 – Thalassemia in the ICD-10 classification system. It is used in clinical documentation, billing, and epidemiological research to uniquely identify hereditary persistence of fetal hemoglobin.
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Average rating of 4.97 out of 5 stars
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Average rating of 4.85 out of 5 stars
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
Average rating of 4.86 out of 5 stars
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
Average rating of 4.94 out of 5 stars
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.